Showing results (791-800 of 1,032) with videos related to

Sort By:
Pageof 104
Nutrients|December 9, 2020
Additive Effects of Omega-3 Fatty Acids and Thiazolidinediones in Mice Fed a High-Fat Diet: Triacylglycerol/Fatty Acid Cycling in Adipose TissueKristina Bardova, Jiri Funda, Radek Pohl, et al.
Kidney360|May 4, 2026
Thyroid Function with Continuous KRT: A Prospective StudyMatthew Kennis, David Madison, North Foulon, et al.
Blood|October 15, 1996
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group studyJ K Weick, K J Kopecky, F R Appelbaum, et al.
Cancer Research|September 17, 2010
Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivorsChristopher I Li, Nobuo Nishi, Jean A McDougall, et al.
Radiology|November 27, 2004
Suspected acute pulmonary embolism: evaluation with multi-detector row CT versus digital subtraction pulmonary arteriographyHelen T Winer-Muram, Jonas Rydberg, Matthew S Johnson, et al.
Urologic Oncology|January 27, 2019
Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national databaseAlexandr Poprach, Kristina Rumanova, Radek Lakomý, et al.
Blood|October 24, 2002
Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group studyJeanne E Anderson, Kenneth J Kopecky, Cheryl L Willman, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery diseaseJoseph Murphy, R Scott Wright, Ihor Gussak, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2021
Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitationsOndrej Uher, Veronika Caisova, Lucie Padoukova, et al.
Targeted Oncology|November 13, 2023
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell CarcinomaAlexandr Poprach, Igor Kiss, Michal Stanik, et al.
Pageof 104